Author:
Korkmaz Yetkin,Çınar Tufan,Şaylık Faysal,Akbulut Tayyar,Selçuk Murat,Oğuz Mustafa,Hayıroğlu Mert Ilker,Tanboğa İbrahim Halil
Abstract
Abstract
Background
Our primary goal was to utilize pulmonary arterial stiffness (PAS) to demonstrate the early alterations in the pulmonary vascular area in individuals with prior COVID-19 illness who had not undergone hospitalization.
Methods
In total, 201 patients with prior COVID-19 infection without hospitalization and 195 healthy, age- and sex-matched individuals without a history of COVID-19 disease were included in this prospective analysis. The PAS value for each patient was calculated by dividing the mean peak pulmonary flow velocity by the pulmonary flow acceleration time.
Results
The measured PAS was 10.2 ± 4.11 Hz/msec in post–COVID-19 participants and 8.56 ± 1.47 Hz/msec in healthy subjects (P < 0.001). Moreover, pulmonary artery acceleration time was significantly lower in patients with a prior history of COVID-19. Multivariable logistic regression analysis revealed that PAS was significantly connected to a prior COVID-19 illness (odds ratio, 1.267; 95% confidence interval, 1.142–1.434; P < 0.001). The optimal cutoff point for detecting a prior COVID-19 disease for PAS was 10.1 (sensitivity, 70.2%; specificity, 87.7%).
Conclusions
This might be the first investigation to reveal that patients with a history of COVID-19 had higher PAS values compared to those without COVID-19. The results of the investigation may indicate the need of regular follow up of COVID-19 patients for the development of pulmonary arterial hypertension, especially during the post–COVID-19 interval.
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Hunter KS, Lammers SR, Shandas R. Pulmonary vascular stiffness: measurement, modeling, and implications in normal and hypertensive pulmonary circulations. Compr Physiol. 2011;1:1413–35.
2. Gupta A, Sharifov OF, Lloyd SG, Tallaj JA, Aban I, Dell’italia LJ, et al. Novel noninvasive assessment of pulmonary arterial stiffness using velocity transfer function. J Am Heart Assoc. 2018;7:e009459.
3. Friesen RM, Schäfer M, Ivy DD, Abman SH, Stenmark K, Browne LP, et al. Proximal pulmonary vascular stiffness as a prognostic factor in children with pulmonary arterial hypertension. Eur Heart J Cardiovasc Imaging. 2019;20:209–17.
4. Görgülü S, Eren M, Yildirim A, Ozer O, Uslu N, Celik S, et al. A new echocardiographic approach in assessing pulmonary vascular bed in patients with congenital heart disease: pulmonary artery stiffness. Anadolu Kardiyol Derg. 2003;3:92–7.
5. Ploegstra MJ, Brokelman JG, Roos-Hesselink JW, Douwes JM, van Osch-Gevers LM, Hoendermis ES, et al. Pulmonary arterial stiffness indices assessed by intravascular ultrasound in children with early pulmonary vascular disease: prediction of advanced disease and mortality during 20-year follow-up. Eur Heart J Cardiovasc Imaging. 2018;19:216–24.